A Conceptual Framework for AI-Integrated Metabolomics in Predictive Health Systems for Resource-Constrained Environments

Notice

This is an unedited manuscript accepted for publication and provided as an Article in Press for early access at the author’s request. The article will undergo copyediting, typesetting, and galley proof review before final publication. Please be aware that errors may be identified during production that could affect the content. All legal disclaimers of the journal apply.

Year : 2026 | Volume : 3 | 02 | Page :
    By

    David Sunday ARAOTI,

  1. Independent Researcher, Policy Practitioner/AI & Governance Specialist, Ogbomosho, Oyo State, nigeria

Abstract

The increasing prevalence of non-communicable diseases (NCDs) continues to place a significant strain on healthcare systems, particularly in low- and middle-income regions where access to early diagnostic infrastructure is limited. Conventional healthcare approaches remain largely reactive, often detecting diseases at advanced stages when treatment effectiveness is reduced. This challenge underscores the need for predictive, cost-effective, and data-driven healthcare solutions. This study presents a conceptual framework that integrates metabolomics with artificial intelligence (AI) to support predictive health systems in resource-constrained environments. Metabolomics enables comprehensive profiling of small-molecule metabolites, providing dynamic insights into physiological and pathological processes. When combined with machine learning techniques, these datasets can be analyzed to identify early biomarkers, assess disease risk, and inform personalized intervention strategies. The proposed framework outlines a multi-layered system architecture comprising metabolite data acquisition, preprocessing, feature extraction, and AI-based predictive modeling. The system is designed to generate clinically relevant outputs, including early diagnostic indicators, risk classification, and decision- support insights for diseases such as diabetes, cardiovascular conditions, and cancer. Emphasis is placed on scalability through the integration of portable diagnostic tools, cloud-based data processing, and decentralized healthcare delivery models. The study also examines key ethical and governance considerations, including data privacy, algorithmic fairness, and equitable access to digital health technologies. By aligning technological innovation with the realities of low-resource settings, the framework aims to enhance early disease detection and improve healthcare outcomes. Overall, this research contributes to the advancement of predictive and precision public health by proposing a scalable, interdisciplinary model that bridges biological data analysis and computational intelligence for improved health system performance in underserved populations.

Keywords: Metabolomics, Artificial Intelligence, Predictive Healthcare, Biomarkers, Precision Medicine, Digital Health, Resource-Constrained Environments

How to cite this article:
David Sunday ARAOTI. A Conceptual Framework for AI-Integrated Metabolomics in Predictive Health Systems for Resource-Constrained Environments. Emerging Trends in Metabolites. 2026; 03(02):-.
How to cite this URL:
David Sunday ARAOTI. A Conceptual Framework for AI-Integrated Metabolomics in Predictive Health Systems for Resource-Constrained Environments. Emerging Trends in Metabolites. 2026; 03(02):-. Available from: https://journals.stmjournals.com/etm/article=2026/view=248027


References

  1. World Health Organization. Legal environment assessment for the prevention of non- communicable diseases: an operational guide. World Health Organization; 2023 Dec 18.
  2. Nicholson JK, Holmes E, Wilson ID. Gut microorganisms, mammalian metabolism, and personalized health care. Nat Rev Microbiol. 2005 May;3(5):431-438. doi:10.1038/nrmicro1152
  3. Patti GJ, Yanes O, Siuzdak G. Metabolomics: the apogee of the omics trilogy. Nat Rev Mol Cell Biol. 2012 Apr;13(4):263-269. doi:10.1038/nrm3314.
  4. Esteva A, Kuprel B, Novoa RA, Ko J, Swetter SM, Blau HM, et al. Dermatologist-level classification of skin cancer with deep neural networks. Nature. 2017 Feb 2;542(7639):115- 118. doi:10.1038/nature21056
  5. Topol E. Deep medicine: how artificial intelligence can make healthcare human again. Hachette UK; 2019 Mar 12.
  6. Floridi L, Cowls J, Beltrametti M, Chatila R, Chazerand P, Dignum V, et al. AI4People—An ethical framework for a good AI society: opportunities, risks, principles, and recommendations. Minds Mach. 2018 Dec;28(4):689-707. doi:10.1007/s11023-018-9482-5.
  7. Nicholson JK, Lindon JC, Holmes E. ‘Metabonomics: understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica. 1999 Nov;29(11):1181-1189. doi:10.1080/004982599238047.
  8. Bollard ME, Stanley EG, Lindon JC, Nicholson JK, Holmes E. NMR-based metabonomic approaches for evaluating physiological influences on biofluid composition. NMR Biomed. 2005 May;18(3):143-162. doi:10.1002/nbm. 943.
  9. Wishart DS. Emerging applications of metabolomics in drug discovery and precision medicine. Nat Rev Drug Discov. 2016 Jul;15(7):473-484. doi:10.1038/nrd.2016.32.
  10. Goodacre R, Vaidyanathan S, Dunn WB, Harrigan GG, Kell DB. Metabolomics by numbers: acquiring and understanding global metabolite data. TRENDS in Biotechnology. 2004 May 1;22(5):245-52.
  11. Johnson CH, Ivanisevic J, Siuzdak G. Metabolomics: beyond biomarkers and towards mechanisms. Nat Rev Mol Cell Biol. 2016 Jul;17(7):451-459. doi:10.1038/nrm.2016.25.
  12. Ogunjobi TT, Ohaeri PN, Akintola OT, Atanda DO, Orji FP, Adebayo JO, et al. Bioinformatics applications in chronic diseases: a comprehensive review of genomic, transcriptomics, proteomic, metabolomics, and machine learning approaches. Medinformatics. 2024 Feb 6. doi:10.1007/s44337-024-00008-5.
  13. Puchades-Carrasco L, Pineda-Lucena A. Metabolomics applications in precision medicine: an oncological perspective. Curr Top Med Chem. 2017;17(24):2740-2751. doi:10.2174/1568026617666170707120034.
  14. Barabási AL, Gulbahce N, Loscalzo J. Network medicine: a network-based approach to human disease. Nat Rev Genet. 2011 Jan;12(1):56-68. doi:10.1038/nrg2918
  15. Awasthi R, Ramachandran SP, Mishra S, Mahapatra D, Arshad H, Atreja A, et al. Artificial intelligence in healthcare: 2024 year in review. medRxiv [Preprint]. 2025 Feb 28:2025.02.26.25322978. doi:10.1101/2025.02.26.25322978.
  16. Kaddurah-Daouk R, Krishnan KR. Metabolomics: a global biochemical approach to the study of central nervous system diseases. Neuropsychopharmacology. 2009 Jan;34(1):173- 186. doi:10.1038/npp.2008.174
  17. Wishart D. S. (2008). Applications of metabolomics in drug discovery and development. Drugs in R&D, 9(5), 307–322.https://doi.org/10.2165/00126839-200809050-00002
  18. Zhou J, Yin Y. Strategies for large-scale targeted metabolomics quantification by liquid chromatography-mass spectrometry. Analyst. 2016;141(23):6362-6373. doi:10.1039/C6AN01774J.
Ahead of Print Subscription Original Research
Volume 03
02
Received 16/04/2026
Accepted 08/05/2026
Published 26/05/2026
Publication Time 40 Days
8

Login


My IP

PlumX Metrics